Search for: "Does 1 - 30" Results 3661 - 3680 of 28,714
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jul 2022, 3:19 am by freddy
  According to officials, the boy had been pulled from the pool prior to the emergency call that was made at about 1:30 p.m. [read post]
22 Jul 2022, 7:48 pm by Mili Gupta
The competent Chamber of the ECtHR relinquished authority to the Grand Chamber in compliance with Article 30 of the ECHR and Rule 72 (1) and (2) of the Rules of the Court. [read post]
22 Jul 2022, 2:11 pm by Eugene Volokh
And only ten days after Bailey's post, on March 30, 2020, so many Americans were hospitalized with COVID-19 in New York City that tents were set up in Central Park to serve as a makeshift hospital. [read post]
22 Jul 2022, 7:51 am by Simon Lovegrove (UK)
For the report, the EBA conducted an ad hoc data-collection exercise involving about 181 EU institutions on the reference date 30 June 2021. [read post]
22 Jul 2022, 5:07 am by John Jascob
Bush on July 30, 2002 signed the Sarbanes-Oxley Act into law after the accounting scandals at Enron and WorldCom Inc. shook markets and U.S. financial regulators. [read post]
21 Jul 2022, 4:44 pm by INFORRM
In January 2020, the ICO imposed a fine of £500,000 on DSG for failing to secure the personal data of at least 14 million customers (see “Monetary Penalty Notice” (ICO, 7 January 2020) (pdf) (an intended appeal against this fine (Warren [2]) does not seem to have come on yet). [read post]
20 Jul 2022, 6:58 am by Levin Papantonio
“In addition, those currently on the U.S. market must be removed, or risk enforcement action,” the FDA stated.Although FDA stayed the marketing denial order on July 5, 2022, the temporary suspension does not mean the order has been rescinded. [read post]
20 Jul 2022, 6:57 am by Eric Goldman
Doe’s negligent design claim similarly aims to hold Snap liable for communications exchanged between Doe and Guess-Mazock. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
Four Myths about Biotech Securities Cases   As discussed in our original article, these findings overturn several longstanding myths about this subset of securities class actions:   Myth #1: Cases against biotech companies for failed clinical trials or products that are not approved by the FDA are risky and expensive. [read post]
19 Jul 2022, 1:20 pm by Simmons Hanly Conroy
It’s a record that still stands today — as does John’s founding mission to put clients first. [read post]
19 Jul 2022, 7:14 am by Nathaniel M. Glasser
For more information about the Ban on Non-Compete Agreements Amendment Act of 2020, contact the District of Columbia Department of Employment Services (DOES). [read post]
For more information about the Ban on Non-Compete Agreements Amendment Act of 2020, contact the District of Columbia Department of Employment Services (DOES). [read post]